Abstract
Busulfan is an alkylating agent widely used in the ablation of bone marrow cells before hematopoietic stem cell transplant. Due to large intraindividual and interindividual variations, and narrow therapeutic window, therapeutic drug monitoring of busulfan is warranted. A quick and reliable HPLC-MS/MS method was developed for the assay of plasma busulfan. HPLC involved C18 column, and MS/MS was used in electrospray ionization (ESI) positive mode. Quantitation and identification of busulfan was made using various multiple reactions monitoring (MRMs). Isotopic labeled busulfan-d8 was used as the internal standard. The method is linear from 50 to 2500 ng/mL and has with-in run and between-run imprecision of <10 %.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cavo M, Bandini G, Benni M, Gozzetti A, Ronconi S, Rosti G, Zamagni E, Lemoli RM, Bonini A, Belardinelli A et al (1998) High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma. Bone Marrow Transplant 22:27–32
O’Donnell MR, Long GD, Parker PM, Niland J, Nademanee A, Amylon M, Chao N, Negrin RS, Schmidt GM, Slovak ML et al (1995) Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia. J Clin Oncol 13:2973–2979
Shah AJ, Lenarsky C, Kapoor N, Crooks GM, Kohn DB, Parkman R, Epport K, Wilson K, Weinberg K (2004) Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation. J Pediatr Hematol Oncol 26:91–97
Slattery JT, Risler LJ (1998) Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation. Ther Drug Monit 20:543–549
Athanasiadou I, Angelis YS, Lyris E, Archontaki H, Georgakopoulos C, Valsami G (2014) Gas chromatographic-mass spectrometric quantitation of busulfan in human plasma for therapeutic drug monitoring: a new on-line derivatization procedure for the conversion of busulfan to 1,4-diiodobutane. J Pharm Biomed Anal 90:207–214
Courtney JB, Harney R, Li Y, Lundell G, McMillin GA, Agarwal G, Juenke JM, Mathew A, Gonzalez-Espinoza R, Fleisher M et al (2009) Determination of busulfan in human plasma using an ELISA format. Ther Drug Monit 31:489–494
Embree L, Burns RB, Heggie JR, Phillips GL, Reece DE, Spinelli JJ, Hartley DO, Hudon NJ, Goldie JH (1993) Gas-chromatographic analysis of busulfan for therapeutic drug monitoring. Cancer Chemother Pharmacol 32:137–142
French D, Sujishi KK, Long-Boyle JR, Ritchie JC (2014) Development and validation of a liquid chromatography-tandem mass spectrometry assay to quantify plasma busulfan. Ther Drug Monit 36:169–174
Hassan M, Ehrsson H (1983) Gas chromatographic determination of busulfan in plasma with electron-capture detection. J Chromatogr 277:374–380
Juenke JM, Miller KA, McMillin GA, Johnson-Davis KL (2011) An automated method for supporting busulfan therapeutic drug monitoring. Ther Drug Monit 33:315–320
Kellogg MD, Law T, Sakamoto M, Rifai N (2005) Tandem mass spectrometry method for the quantification of serum busulfan. Ther Drug Monit 27:625–629
Lai WK, Pang CP, Law LK, Wong R, Li CK, Yuen PM (1998) Routine analysis of plasma busulfan by gas chromatography-mass fragmentography. Clin Chem 44:2506–2510
Moon SY, Lim MK, Hong S, Jeon Y, Han M, Song SH, Lim KS, Yu KS, Jang IJ, Lee JW et al (2014) Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometry. Ann Lab Med 34:7–14
Murdter TE, Coller J, Claviez A, Schonberger F, Hofmann U, Dreger P, Schwab M (2001) Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometry. Clin Chem 47:1437–1442
Quernin MH, Duval M, Litalien C, Vilmer E, Aigrain EJ (2001) Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry. Application to pharmacokinetic studies in children. J Chromatogr B Biomed Sci Appl 763:61–69
Vassal G, Re M, Gouyette A (1988) Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard. J Chromatogr 428:357–361
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Deng, S., Kiscoan, M., Frazee, C., Abdel-Rahman, S., Dalal, J., Garg, U. (2016). A Simple Liquid Chromatography Tandem Mass Spectrometry Method for Quantitation of Plasma Busulfan. In: Garg, U. (eds) Clinical Applications of Mass Spectrometry in Drug Analysis. Methods in Molecular Biology, vol 1383. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3252-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3252-8_9
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3251-1
Online ISBN: 978-1-4939-3252-8
eBook Packages: Springer Protocols